All Pharmaceutical Microbiology articles – Page 14
-
NewsA new ally against tooth decay: Arginine offers sweet relief
A new human clinical trial finds arginine can prevent caries due to bacterial plaques by reducing the acidity, altering the plaque structure and reducing harmful bacteria in the plaques.
-
NewsPlant-derived phenolic acids revive the power of tetracycline against drug-resistant bacteria
A study demonstrates that plant-derived phenolic acids can act as powerful antibiotic adjuvants by restoring and enhancing tetracycline efficacy against multidrug-resistant bacteria through multi-target disruption of key resistance mechanisms.
-
NewsDiscovery could lead to new treatments for drug-resistant fungal infections
Researchers have identified a molecule that may help turn the tide on fungal infections — butyrolactol A, a chemical compound that targets a deadly, disease-causing fungi called Cryptococcus neoformans.
-
NewsNew clinical standards strengthen antimicrobial stewardship in tuberculosis care
An international panel of experts from 32 countries has presented specific antimicrobial stewardship standards for TB care for the first time.
-
NewsHigh-dose antibiotic does not reduce mortality in tuberculous meningitis
The first trial examining the effects of higher rifampicin doses on tuberculosis survival has been completed. The study found no evidence of a beneficial effect from high-dose rifampicin.
-
NewsResearchers use robotics to find potential new antibiotic among hundreds of metal complexes
Researchers have used a cutting-edge robotic system capable of synthesising hundreds of metal complexes to develop a possible antibiotic candidate - offering fresh hope in the global fight against drug-resistant infections.
-
NewsThe antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella
A study shows, in an experimental laboratory model, that delafloxacin inhibits the intracellular replication of Legionella more effectively than one of the current standard treatments.
-
NewsEvaluation of antiviral activity of organic–polyoxometalate hybrids based on berberine against encephalomyocarditis virus in vitro
A new study promotes the development of POM-based drugs for clinical application by controlling the organic cations on the surface of organic–POM hybrids, ultimately yielding new POM drugs with high efficiency and low toxicity.
-
NewsNew antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.
-
NewsCancer-fighting bacterial product ‘cocktails’ may offer personalized treatment
Bacteria may be the next frontier in cancer treatment, according to researchers who devised a new approach of creating bacteria-derived mixtures — or cocktails — to help fight bladder cancer. They found that the cocktails significantly boost the immune system’s ability to fight cancer.
-
NewsResearchers see dramatic drop in HIV-infected immune cells in patient after cancer treatment received
Researchers report they may have taken an early step toward a more practical HIV cure. They focused on a patient undergoing cancer treatment and also living with HIV, who after receiving chemotherapy, had a significant reduction in the number of CD4+ T immune cells that contained an HIV provirus.
-
NewsStrategic advancement of second-generation fungal vaccine VXV-01 through Phase 1 trials
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) have announced that the second-generation fungal vaccine candidate known as VXV‑01 is poised to move forward in development up to and including Phase 1 clinical evaluation.
-
NewsMutated baker’s yeast at the forefront of petroleum substitute tech
Researchers engineering Saccharomyces cerevisiae to produce 2,3-butanediol (2,3-BDO) introduced mutations into the genomic DNA. The researchers engineered four altered strains and subjected them to ethanol, heat, and low pH stressors.
-
NewsUnique bond identified as key to viral infection speed
Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research reveals a deliberate imbalance in their shape that helps them infect their hosts.
-
NewsOpioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections. The meta-analysis examined four studies of almost 120,000 patients. The researchers found that about 31% of patients who were prescribed and taking opioids caught C. diff, compared to 17% of patients who weren’t using them.
-
NewsCloves and miswak: Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common pathogens in vitro
Clove essential oil (CEO) derived from Syzygium aromaticum and miswak (Salvadora persica) contains bioactive compounds with antimicrobial properties. This study aimed to evaluate the in vitro antimicrobial efficacy of CEO, miswak, and their combination against key peri-implantitis pathogens.
-
NewsNew method to accelerate vaccine and drug development for norovirus
Researchers have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.
-
NewsTuberculosis: Scientists develop novel drug candidate for combating resistant pathogens
Researchers have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits the pathogens’ ability to produce energy and causes them to die.
-
NewsOld molecules show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2 continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, researchers have identified several promising molecules that could lead to new medications capable of combating these resistant variants.
-
NewsNature’s 10: Ten people who shaped science in 2025
Microbiologists and scientists tackling infectious diseases are among Nature’s annual list of ten people at the heart of some of the biggest science stories of 2025.